Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
DNA Ginkgo Bioworks Holdings, Inc.
© 2025 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement ...
With the start of the new year, Preserving Home is building on a new chapter… Windjam Companies is a privately held, Cary-based parent company specializing in luxury real estate… Join Triangle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback